PGR (Progesterone receptor) variants and mutations
PGR (also known as Progesterone receptor) is a human protein-coding gene encoding a progesterone receptor protein. It converts progesterone binding into transcriptional programs governing reproductive-tract function, implantation, pregnancy, and mammary development. Altered signaling is important in hormone-responsive cancers and is targeted clinically by progesterone agonists and antagonists. This analysis covers 1,427 PGR variants and mutations. Of these, 89% have computational variant effect predictions. Disease context includes endometriosis, Infertility, and contraception. Example PGR variants include E3A, L4P, and K5T.
Variant analysis overview
- Gene: PGR
- Protein: Progesterone receptor
- UniProt accession: P06401
- Organism: Homo sapiens
- Variants analyzed: 1427
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 1,154 unspecified-consequence records; 112 synonymous variants; 138 missense variants; 1 protein altering variant; 8 frameshift variants; 2 splice-region variants; 1 stop lost; 4 stop-gained variants; 2 in-frame deletions; 1 in-frame insertions; 4 substitution
- Prediction scores: 1,268 variants have prediction scores (89% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: endometriosis, Infertility, contraception, acne, Dysmenorrhea, breast cancer, hemorrhage, Uterine leiomyoma, Menorrhagia, Anorexia, amenorrhea, leiomyoma.
Protein structure and variant hotspots
- Protein features: 1 domains; 1 binding sites; 11 post-translational modification sites.
- Structural context: 426 variants have structural context.
- PTM context: 16 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable PGR variants
Examples include E3A, L4P, K5T, A6T, A6V, G8C, G8S, P9L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- E3A (p.Glu3Ala), gnomAD rs1196735070, REVEL 0.23, CADD 26.00
- L4P (p.Leu4Pro), TOPMed rs1481763731, gnomAD rs1481763731, REVEL 0.08, CADD 14.80
- K5T (p.Lys5Thr), gnomAD rs1256369660, REVEL 0.03, CADD 17.10
- A6T (p.Ala6Thr), gnomAD rs1425983653, REVEL 0.12, CADD 23.40
- A6V (p.Ala6Val), 1000Genomes rs202123793, REVEL 0.15, CADD 25.70
- G8C (p.Gly8Cys), NCI-TCGA TCGA novel, REVEL 0.09, CADD 23.00, Variant assessed as somatic; moderate impact.
- G8S (p.Gly8Ser), Ensembl rs1863012219, REVEL 0.04, CADD 19.70
- P9L (p.Pro9Leu), ExAC rs757679709, TOPMed rs757679709, gnomAD rs757679709, REVEL 0.03, CADD 20.40
- P9R (p.Pro9Arg), ExAC rs757679709, TOPMed rs757679709, gnomAD rs757679709, REVEL 0.10, CADD 23.80
- R10L (p.Arg10Leu), TOPMed rs1025431009, gnomAD rs1025431009, REVEL 0.17, CADD 22.60, Uncertain significance
- R10Q (p.Arg10Gln), rs1025431009, ClinGen CA382482260, ClinVar RCV004087894, TOPMed rs1025431009, REVEL 0.04, CADD 15.90, Uncertain significance, not specified
- A11V (p.Ala11Val), ExAC rs754148309, TOPMed rs754148309, gnomAD rs754148309, REVEL 0.07, CADD 23.40
- P12A (p.Pro12Ala), gnomAD rs1300411195, REVEL 0.10, CADD 22.50
- P12L (p.Pro12Leu), TOPMed rs973621938, gnomAD rs973621938, REVEL 0.04, CADD 23.20
- P12T (p.Pro12Thr), gnomAD rs1300411195, REVEL 0.10, CADD 23.80
- H13Q (p.His13Gln), TOPMed rs1391730145, gnomAD rs1391730145, REVEL 0.21, CADD 23.90
- H13Y (p.His13Tyr), Ensembl rs972790750, REVEL 0.20, CADD 25.40
- V14L (p.Val14Leu), ExAC rs760920621, TOPMed rs760920621, gnomAD rs760920621, REVEL 0.09, CADD 22.40
- A15E (p.Ala15Glu), TOPMed rs1328901959, gnomAD rs1328901959, REVEL 0.07, CADD 18.90
- A15V (p.Ala15Val), cosmic curated COSV54795, TOPMed rs1328901959, gnomAD rs1328901959, REVEL 0.05, CADD 22.40
- G16D (p.Gly16Asp), TOPMed rs962434146, gnomAD rs962434146, REVEL 0.03, CADD 17.90
- G17C (p.Gly17Cys), TOPMed rs1863009569, REVEL 0.02, CADD 16.50
- G17D (p.Gly17Asp), ExAC rs767664725, gnomAD rs767664725, REVEL 0.04, CADD 16.00
- G17S (p.Gly17Ser), cosmic curated COSV54811, TOPMed rs1863009569, REVEL 0.01, CADD 10.60
- G17V (p.Gly17Val), ExAC rs767664725, gnomAD rs767664725, REVEL 0.04, CADD 18.90
- P18L (p.Pro18Leu), cosmic curated COSV10584, ExAC rs759568940, TOPMed rs759568940, gnomAD rs759568940, REVEL 0.02, CADD 20.60
- P18Q (p.Pro18Gln), ExAC rs759568940, TOPMed rs759568940, gnomAD rs759568940, REVEL 0.06, CADD 20.20
- P18R (p.Pro18Arg), ExAC rs759568940, TOPMed rs759568940, gnomAD rs759568940, REVEL 0.03, CADD 20.30
- S20F (p.Ser20Phe), rs774399131, NCI-TCGA Cosmic COSV5481, cosmic curated COSV54810, ExAC rs774399131, REVEL 0.16, CADD 25.50, Variant assessed as somatic; moderate impact.
- S20P (p.Ser20Pro), TOPMed rs199841157, gnomAD rs199841157, REVEL 0.13, CADD 23.50
- P21S (p.Pro21Ser), cosmic curated COSV54805, ExAC rs770746610, TOPMed rs770746610, gnomAD rs770746610, REVEL 0.05, CADD 16.80, Uncertain significance, not specified
- V23A (p.Val23Ala), Ensembl rs1863008380, REVEL 0.02, CADD 8.29
- G24R (p.Gly24Arg), NCI-TCGA TCGA novel, REVEL 0.06, CADD 13.80, Variant assessed as somatic; moderate impact.
- G24V (p.Gly24Val), cosmic curated COSV54805, gnomAD rs1365969218, REVEL 0.07, CADD 21.10
- S25F (p.Ser25Phe), NCI-TCGA Cosmic COSV5481, cosmic curated COSV54810, Variant assessed as somatic; moderate impact.
- S25P (p.Ser25Pro), ExAC rs772873062, gnomAD rs772873062, REVEL 0.10, CADD 15.20
- P26L (p.Pro26Leu), TOPMed rs1863007751
- L27P (p.Leu27Pro), NCI-TCGA Cosmic COSV5480, cosmic curated COSV54804, Variant assessed as somatic; moderate impact.
- L28P (p.Leu28Pro), ExAC rs747756907, gnomAD rs747756907, REVEL 0.09, CADD 19.40
- C29* (p.Cys29Ter), ExAC rs754528074, gnomAD rs754528074, CADD 27.80
- C29R (p.Cys29Arg), rs1863007121, ClinGen CA382482160, ClinVar RCV004356377, TOPMed rs1863007121, REVEL 0.02, CADD 16.20, Uncertain significance, not specified
- C29Y (p.Cys29Tyr), 1000Genomes rs567202506, ExAC rs567202506, gnomAD rs567202506, REVEL 0.03, CADD 17.60
- R30G (p.Arg30Gly), TOPMed rs1016622652, gnomAD rs1016622652, REVEL 0.23, CADD 17.40
- P31L (p.Pro31Leu), ExAC rs746468525, gnomAD rs746468525, REVEL 0.02, CADD 4.96
- P31S (p.Pro31Ser), TOPMed rs1372643781, REVEL 0.04, CADD 9.26
- A32V (p.Ala32Val), TOPMed rs1863005807
- A33S (p.Ala33Ser), gnomAD rs1197704457, REVEL 0.03, CADD 3.46
- A33V (p.Ala33Val), rs779538755, ExAC rs779538755, gnomAD rs779538755, REVEL 0.02, CADD 10.40, Variant assessed as somatic; moderate impact.
- G34C (p.Gly34Cys), ExAC rs757691518, gnomAD rs757691518, REVEL 0.21, CADD 19.50
- G34S (p.Gly34Ser), ExAC rs757691518, gnomAD rs757691518, REVEL 0.10, CADD 17.50
- P35L (p.Pro35Leu), cosmic curated COSV99679, gnomAD rs1393764426, REVEL 0.06, CADD 15.30
- F36L (p.Phe36Leu), ExAC rs764487268, TOPMed rs764487268, gnomAD rs764487268, REVEL 0.03, CADD 16.10
- F36V (p.Phe36Val), Ensembl rs2135518453
- P37L (p.Pro37Leu), ESP rs146230124, ExAC rs146230124, TOPMed rs146230124, gnomAD rs146230124, REVEL 0.00, CADD 6.62, Uncertain significance, not specified
- P37R (p.Pro37Arg), ESP rs146230124, ExAC rs146230124, TOPMed rs146230124, gnomAD rs146230124, REVEL 0.00, CADD 0.51, Uncertain significance
- P37T (p.Pro37Thr), NCI-TCGA Cosmic COSV9967, cosmic curated COSV99678, Variant assessed as somatic; moderate impact.
- G38E (p.Gly38Glu), 1000Genomes rs547307017, ExAC rs547307017, TOPMed rs547307017, gnomAD rs547307017, REVEL 0.04, CADD 4.08
- S39I (p.Ser39Ile), gnomAD rs1445536210, REVEL 0.04, CADD 18.00
- S39R (p.Ser39Arg), 1000Genomes rs536303000, ExAC rs536303000, TOPMed rs536303000, gnomAD rs536303000, REVEL 0.08, CADD 20.80
- Q40K (p.Gln40Lys), ESP rs372843224, ExAC rs372843224, TOPMed rs372843224, gnomAD rs372843224, REVEL 0.04, CADD 17.10
- T41I (p.Thr41Ile), rs577094242, ClinGen CA228195713, cosmic curated COSV54796, ClinVar RCV004146391, REVEL 0.03, CADD 11.20, Uncertain significance, not specified
- T41N (p.Thr41Asn), TOPMed rs577094242, Uncertain significance
- S42W (p.Ser42Trp), Ensembl rs1863002919
- T44I (p.Thr44Ile), ESP rs141862537, ExAC rs141862537, TOPMed rs141862537, gnomAD rs141862537, REVEL 0.05, CADD 14.80
- T44N (p.Thr44Asn), rs141862537, NCI-TCGA Cosmic COSV5479, cosmic curated COSV54795, ESP rs141862537, REVEL 0.03, CADD 8.24, Variant assessed as somatic; moderate impact.
- T44S (p.Thr44Ser), ESP rs141862537, ExAC rs141862537, TOPMed rs141862537, gnomAD rs141862537
- L45F (p.Leu45Phe), NCI-TCGA Cosmic COSV5480, cosmic curated COSV54806, NCI-TCGA Cosmic COSV9967, REVEL 0.02, CADD 12.50, Variant assessed as somatic; moderate impact.
- P46H (p.Pro46His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P46L (p.Pro46Leu), gnomAD rs1283697257, REVEL 0.08, CADD 20.10
- P46R (p.Pro46Arg), gnomAD rs1283697257, REVEL 0.06, CADD 18.70
- P46S (p.Pro46Ser), gnomAD rs1863002000, REVEL 0.03, CADD 8.87
- E47K (p.Glu47Lys), cosmic curated COSV54812, ESP rs148270826, ExAC rs148270826, TOPMed rs148270826, REVEL 0.02, CADD 10.20, Variant assessed as somatic; high impact.
- E47Q (p.Glu47Gln), ESP rs148270826, ExAC rs148270826, TOPMed rs148270826, gnomAD rs148270826, REVEL 0.02, CADD 8.28
- S49L (p.Ser49Leu), rs1349242903, gnomAD rs1349242903, REVEL 0.15, CADD 20.50, Variant assessed as somatic; moderate impact.
- A50D (p.Ala50Asp), rs771472590, ClinGen CA6243959, ClinVar RCV004498764, ExAC rs771472590, REVEL 0.11, CADD 17.10, Uncertain significance, not specified
- A50T (p.Ala50Thr), rs11571143, UniProt VAR 019221, 1000Genomes rs11571143, ExAC rs11571143, REVEL 0.04, CADD 8.51
- A50V (p.Ala50Val), NCI-TCGA Cosmic COSV5479, cosmic curated COSV54799, Variant assessed as somatic; moderate impact.
- I51M (p.Ile51Met), TOPMed rs1373987810, gnomAD rs1373987810, REVEL 0.15, CADD 2.10
- I51T (p.Ile51Thr), rs113635284, ClinGen CA6243958, ClinVar RCV000967235, 1000Genomes rs113635284, REVEL 0.15, CADD 15.00, Benign, not provided
- P52R (p.Pro52Arg), gnomAD rs1402461722, REVEL 0.19, CADD 23.10
- I53M (p.Ile53Met), TOPMed rs1862999730
- S54F (p.Ser54Phe), cosmic curated COSV54809, ESP rs369863850, ExAC rs369863850, TOPMed rs369863850, REVEL 0.30, CADD 26.10
- S54Y (p.Ser54Tyr), ESP rs369863850, ExAC rs369863850, TOPMed rs369863850, gnomAD rs369863850, REVEL 0.28, CADD 25.40
- G57R (p.Gly57Arg), 1000Genomes rs3740754, ExAC rs3740754, TOPMed rs3740754, gnomAD rs3740754, REVEL 0.04, CADD 16.00
- G57W (p.Gly57Trp), cosmic curated COSV99678, 1000Genomes rs3740754, ExAC rs3740754, TOPMed rs3740754, REVEL 0.20, CADD 23.40
- L58V (p.Leu58Val), ExAC rs751677036, TOPMed rs751677036, gnomAD rs751677036, REVEL 0.20, CADD 22.70
- L59F (p.Leu59Phe), NCI-TCGA Cosmic COSV1043, NCI-TCGA Cosmic COSV5479, cosmic curated COSV54799, Variant assessed as somatic; moderate impact.
- L59I (p.Leu59Ile), cosmic curated COSV10437, Ensembl rs1862998748
- F60C (p.Phe60Cys), gnomAD rs1373734471, REVEL 0.16, CADD 23.10
- F60L (p.Phe60Leu), gnomAD rs1472554109, REVEL 0.25, CADD 23.80
- P61A (p.Pro61Ala), TOPMed rs1489270172, gnomAD rs1489270172, REVEL 0.14, CADD 17.90
- P61H (p.Pro61His), 1000Genomes rs200145151, REVEL 0.24, CADD 25.40
- P61S (p.Pro61Ser), NCI-TCGA Cosmic COSV9967, cosmic curated COSV99679, REVEL 0.07, CADD 15.50, Variant assessed as somatic; moderate impact.
- P61T (p.Pro61Thr), TOPMed rs1489270172, gnomAD rs1489270172
- R62W (p.Arg62Trp), cosmic curated COSV54808, ExAC rs762965993, gnomAD rs762965993, REVEL 0.11, CADD 23.40
- C64F (p.Cys64Phe), cosmic curated COSV54809, ExAC rs750407171, gnomAD rs750407171, REVEL 0.20, CADD 24.40
- C64R (p.Cys64Arg), Ensembl rs868152278
- C64S (p.Cys64Ser), ExAC rs750407171, gnomAD rs750407171, REVEL 0.07, CADD 19.30
- Q65* (p.Gln65Ter), ExAC rs765125484, gnomAD rs765125484, CADD 37.00
- G66A (p.Gly66Ala), TOPMed rs1391427840, gnomAD rs1391427840, REVEL 0.01, CADD 6.27, Uncertain significance, not specified
- G66R (p.Gly66Arg), TOPMed rs1301553115, gnomAD rs1301553115, REVEL 0.13, CADD 23.20
- P69L (p.Pro69Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P69S (p.Pro69Ser), ExAC rs776395620, TOPMed rs776395620, gnomAD rs776395620, REVEL 0.01, CADD 0.43
- D71C (p.Asp71Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- D71E (p.Asp71Glu), TOPMed rs1273531419
- D71N (p.Asp71Asn), cosmic curated COSV54812, TOPMed rs1216075683
- E72G (p.Glu72Gly), gnomAD rs1862995460, REVEL 0.01, CADD 0.74
- E72K (p.Glu72Lys), rs868064003, NCI-TCGA Cosmic COSV9967, cosmic curated COSV99678, Ensembl rs868064003, AlphaMissense 0.07, MetaLR 0.02, Variant assessed as somatic; moderate impact.
- K73N (p.Lys73Asn), gnomAD rs1355191904
- T74M (p.Thr74Met), cosmic curated COSV54800, TOPMed rs1862995082, gnomAD rs1862995082, REVEL 0.06, CADD 23.00
- T74R (p.Thr74Arg), TOPMed rs1862995082, gnomAD rs1862995082
- Q75H (p.Gln75His), NCI-TCGA Cosmic COSV5480, cosmic curated COSV54805, Variant assessed as somatic; moderate impact.
- Q75K (p.Gln75Lys), rs147067970, ClinGen CA6243945, cosmic curated COSV54797, ClinVar RCV000881915, REVEL 0.05, CADD 9.99, Likely benign, not provided
- D76V (p.Asp76Val), Ensembl rs918317234
- Q78E (p.Gln78Glu), ExAC rs771435218, TOPMed rs771435218, gnomAD rs771435218, REVEL 0.03, CADD 12.40
- Q78K (p.Gln78Lys), ExAC rs771435218, TOPMed rs771435218, gnomAD rs771435218, REVEL 0.04, CADD 14.30
- S79L (p.Ser79Leu), ExAC rs745363836, gnomAD rs745363836
- L80Q (p.Leu80Gln), NCI-TCGA Cosmic COSV9967, cosmic curated COSV99677, Variant assessed as somatic; moderate impact.
- L80V (p.Leu80Val), rs968931479, []
- S81* (p.Ser81Ter), ExAC rs778465984, gnomAD rs778465984, CADD 35.00
- S81L (p.Ser81Leu), cosmic curated COSV54796, ExAC rs778465984, gnomAD rs778465984, REVEL 0.03, CADD 21.50
- S81P (p.Ser81Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V83A (p.Val83Ala), Ensembl rs1862992882, REVEL 0.03, CADD 21.30
- V83L (p.Val83Leu), TOPMed rs1862993021, REVEL 0.07, CADD 23.30
- V83M (p.Val83Met), NCI-TCGA TCGA novel, TOPMed rs1862993021, REVEL 0.12, CADD 23.80, Variant assessed as somatic; moderate impact.
- E84K (p.Glu84Lys), TOPMed rs1862992721
- G85R (p.Gly85Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G85S (p.Gly85Ser), TOPMed rs972479477
- A86T (p.Ala86Thr), rs868723861, NCI-TCGA Cosmic COSV5480, cosmic curated COSV54803, Ensembl rs868723861, AlphaMissense 0.07, MetaLR 0.02, Variant assessed as somatic; moderate impact.
- Y87H (p.Tyr87His), ExAC rs751679548, TOPMed rs751679548, gnomAD rs751679548, REVEL 0.04, CADD 22.30, Uncertain significance
- Y87N (p.Tyr87Asn), rs751679548, ClinGen CA382486294, ClinVar RCV004498767, ExAC rs751679548, REVEL 0.04, CADD 18.60, Uncertain significance, not specified
- A90P (p.Ala90Pro), Ensembl rs1862991561, Uncertain significance, not specified
- E91K (p.Glu91Lys), cosmic curated COSV10800, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A92D (p.Ala92Asp), TOPMed rs1862991270, REVEL 0.09, CADD 22.30
- T93R (p.Thr93Arg), gnomAD rs1476871650, REVEL 0.06, CADD 13.80
- R94G (p.Arg94Gly), Ensembl rs1862990941, REVEL 0.01, CADD 3.96
- R94K (p.Arg94Lys), ExAC rs780296630, TOPMed rs780296630, gnomAD rs780296630, REVEL 0.01, CADD 3.77
- R94M (p.Arg94Met), cosmic curated COSV10584, ExAC rs780296630, TOPMed rs780296630, gnomAD rs780296630, REVEL 0.03, CADD 14.60
- R94S (p.Arg94Ser), ExAC rs758446042, gnomAD rs758446042, REVEL 0.02, CADD 4.89
- R94T (p.Arg94Thr), ExAC rs780296630, TOPMed rs780296630, gnomAD rs780296630
- G95C (p.Gly95Cys), ExAC rs750494595, TOPMed rs750494595, gnomAD rs750494595, REVEL 0.08, CADD 20.10
- A96G (p.Ala96Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G98D (p.Gly98Asp), Ensembl rs1862990021, REVEL 0.02, CADD 11.00
- G98S (p.Gly98Ser), ExAC rs765215496, gnomAD rs765215496, REVEL 0.03, CADD 12.00
- S100C (p.Ser100Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S100T (p.Ser100Thr), gnomAD rs1248300760
- S101C (p.Ser101Cys), NCI-TCGA Cosmic COSV9967, cosmic curated COSV99677, 1000Genomes rs573557192, ExAC rs573557192, Variant assessed as somatic; moderate impact.
- S101Y (p.Ser101Tyr), 1000Genomes rs573557192, ExAC rs573557192, gnomAD rs573557192, REVEL 0.07, CADD 23.20
- S102G (p.Ser102Gly), ExAC rs763755581, gnomAD rs763755581, REVEL 0.03, CADD 11.80
- S102I (p.Ser102Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S102R (p.Ser102Arg), Ensembl rs1565374613
- P103L (p.Pro103Leu), cosmic curated COSV54798, gnomAD rs1256796821, REVEL 0.02, CADD 11.60
- P103S (p.Pro103Ser), ESP rs369804923, ExAC rs369804923, TOPMed rs369804923, gnomAD rs369804923, REVEL 0.03, CADD 12.70
- P104L (p.Pro104Leu), TOPMed rs1029274929
- P104Q (p.Pro104Gln), TOPMed rs1029274929
- P104R (p.Pro104Arg), TOPMed rs1029274929
- E105* (p.Glu105Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E105K (p.Glu105Lys), TOPMed rs1224677146, gnomAD rs1224677146, REVEL 0.03, CADD 21.30
- D107E (p.Asp107Glu), ESP rs147932536, ExAC rs147932536, TOPMed rs147932536, gnomAD rs147932536, REVEL 0.16, CADD 22.80
- D107G (p.Asp107Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D107N (p.Asp107Asn), Ensembl rs998082338
- S108G (p.Ser108Gly), cosmic curated COSV10584, ExAC rs771726033, gnomAD rs771726033, REVEL 0.02, CADD 11.50
- S108I (p.Ser108Ile), rs1324015244, NCI-TCGA Cosmic COSV5480, cosmic curated COSV54804, TOPMed rs1324015244, REVEL 0.05, CADD 22.90, Variant assessed as somatic; moderate impact.
- S108R (p.Ser108Arg), gnomAD rs1436170445, REVEL 0.02, CADD 9.43
- G109A (p.Gly109Ala), Ensembl rs1862986839
- G109R (p.Gly109Arg), cosmic curated COSV54797, TOPMed rs1862986980, REVEL 0.03, CADD 16.60
- L111M (p.Leu111Met), ExAC rs759187454, REVEL 0.18, CADD 23.50
- L111P (p.Leu111Pro), rs773988513, ClinGen CA6243923, ClinVar RCV004124385, ExAC rs773988513, REVEL 0.27, CADD 27.20, Uncertain significance, not specified
- D112N (p.Asp112Asn), TOPMed rs1862986376
- S113R (p.Ser113Arg), Ensembl rs1862986218
- V114D (p.Val114Asp), gnomAD rs1020891178, REVEL 0.29, CADD 25.70
- V114G (p.Val114Gly), gnomAD rs1020891178, REVEL 0.24, CADD 24.90
- L115F (p.Leu115Phe), ExAC rs770441117, TOPMed rs770441117, gnomAD rs770441117
- D116E (p.Asp116Glu), NCI-TCGA Cosmic COSV5480, cosmic curated COSV54800, Variant assessed as somatic; moderate impact.
- D116H (p.Asp116His), gnomAD rs1862985470, REVEL 0.16, CADD 25.00
- T117S (p.Thr117Ser), ExAC rs748602793, TOPMed rs748602793, gnomAD rs748602793, REVEL 0.06, CADD 22.60
- A120V (p.Ala120Val), rs11571144, ClinGen CA6243918, cosmic curated COSV54800, ClinVar RCV000880422, REVEL 0.10, CADD 16.60, Benign, not provided
- A120S (p.Ala120Ser), rs962335075, []
- P121S (p.Pro121Ser), gnomAD rs1193989741, REVEL 0.14, CADD 22.60
- G123D (p.Gly123Asp), TOPMed rs1477586939, gnomAD rs1477586939, REVEL 0.06, CADD 11.60
Public PGR analysis runs
- PGR analysis run — PGR (1,427 variants) — completed 2026-08-19